AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Physician looking out a window

Physicians in these 10 specialties are less likely to quit

| 6 Min Read
Perturbed patient holds up hands during an appointment

Only 1 in 3 doctors trusts insurers’ prior authorization promises

| 6 Min Read
Senior man looks off into the distance

As population ages, need for practicing geriatricians grows more acute

| 5 Min Read
Jason Mitchell, MD, featured on "Health vs. Hype" AMA podcast (episode 3)

9 things patients should know about taking creatine

| 5 Min Read